Cargando…
Therapeutic Advances in Multiple Sclerosis
Multiple sclerosis (MS) is an autoimmune disease affecting the central nervous system that causes significant disability and healthcare burden. The treatment of MS has evolved over the past three decades with development of new, high efficacy disease modifying therapies targeting various mechanisms...
Autores principales: | Yang, Jennifer H., Rempe, Torge, Whitmire, Natalie, Dunn-Pirio, Anastasie, Graves, Jennifer S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205455/ https://www.ncbi.nlm.nih.gov/pubmed/35720070 http://dx.doi.org/10.3389/fneur.2022.824926 |
Ejemplares similares
-
Refractory Status Epilepticus Associated With a Pathogenic Variant in TNFRSF13B
por: Yang, Jennifer H, et al.
Publicado: (2023) -
Expanding the Potential Therapeutic Options for Remote Ischemic Preconditioning: Use in Multiple Sclerosis
por: Camara-Lemarroy, Carlos R., et al.
Publicado: (2018) -
Neurosarcoidosis following Immune Checkpoint Inhibition
por: Dunn-Pirio, Anastasie M., et al.
Publicado: (2018) -
Postictal Magnetic Resonance Imaging Changes Masquerading as Brain Tumor Progression: A Case Series
por: Dunn-Pirio, Anastasie M., et al.
Publicado: (2016) -
Editorial: Immunosenescence and multiple sclerosis: Prognostic and therapeutic implications
por: Zanghì, Aurora, et al.
Publicado: (2022)